Artículos

Antipsychotic-induced weight gain: bipolar disorder and leptin / McIntyre, Roger S. en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 323-327 Título : Antipsychotic-induced weight gain: bipolar disorder and leptin Tipo de documento: texto impreso Autores: McIntyre, Roger S., Autor ; Deborah A. Mancini, Autor ; Vincenzo S. Basile, Autor Fecha de publicación: 2023 Artículo en la página: pp. 323-327 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Leptina, Pirenzepina, Risperidona. Resumen: Novel antipsychotics impart substantial weight gain. Persons with bipolar disorder are frequently treated with these and other agents known to impart substantial weight gain. We sought to describe the influence of adjunctive risperidone and olanzapine on body weight, body mass index (BMI, kg/m2) and serum leptin levels over a prospective observation period of 6 months. Link: ./index.php?lvl=notice_display&id=31005 [artículo] Antipsychotic-induced weight gain: bipolar disorder and leptin [texto impreso] / McIntyre, Roger S., Autor ; Deborah A. Mancini, Autor ; Vincenzo S. Basile, Autor . - 2023 . - pp. 323-327. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 323-327 Palabras clave: Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Índice de masa corporal, Leptina, Pirenzepina, Risperidona. Resumen: Novel antipsychotics impart substantial weight gain. Persons with bipolar disorder are frequently treated with these and other agents known to impart substantial weight gain. We sought to describe the influence of adjunctive risperidone and olanzapine on body weight, body mass index (BMI, kg/m2) and serum leptin levels over a prospective observation period of 6 months. Link: ./index.php?lvl=notice_display&id=31005

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database / Frank Gianfrancesco en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 328-335 Título : Antipsychotic-induced type 2 diabetes: evidence from a large health plan database Tipo de documento: texto impreso Autores: Frank Gianfrancesco, Autor ; Richard White, Autor ; Ruey-hua Wang, Autor Fecha de publicación: 2023 Artículo en la página: pp. 328-335 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Diabetes mellitus tipo 2, Agentes hipoglucemiantes Resumen: Case evidence suggests that some of the atypical antipsychotics may induce type 2 diabetes. The objective of this study was to evaluate the association of antipsychotic treatment with type 2 diabetes in a large health plan database. Claims data for patients with psychosis within a health plan of nearly 2 million members were analyzed using logistic regression. Link: ./index.php?lvl=notice_display&id=31006 [artículo] Antipsychotic-induced type 2 diabetes: evidence from a large health plan database [texto impreso] / Frank Gianfrancesco, Autor ; Richard White, Autor ; Ruey-hua Wang, Autor . - 2023 . - pp. 328-335. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 328-335 Palabras clave: Antipsicóticos, Diabetes mellitus tipo 2, Agentes hipoglucemiantes Resumen: Case evidence suggests that some of the atypical antipsychotics may induce type 2 diabetes. The objective of this study was to evaluate the association of antipsychotic treatment with type 2 diabetes in a large health plan database. Claims data for patients with psychosis within a health plan of nearly 2 million members were analyzed using logistic regression. Link: ./index.php?lvl=notice_display&id=31006

Serum antimuscarinic activity during clozapine treatment / Jose de Leon en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 336-341 Título : Serum antimuscarinic activity during clozapine treatment Tipo de documento: texto impreso Autores: Jose de Leon, Autor ; Aruby Odom White, Autor ; Richard C. Josiassen, Autor Fecha de publicación: 2023 Artículo en la página: pp. 336-341 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Clozapina, Antagonistas muscarínicos, Esquizofrenia. Resumen: This study attempts: (1) to verify that serum antimuscarinic activity is related to clozapine dose, and more importantly to clozapine plasma concentrations; (2) to explore whether norclozapine has serum antimuscarinic activity; (3) to explore whether antimuscarinic activity is related to clozapine side effects; and (4) to compare the serum antimuscarinic activities of clozapine with those of antiparkinsonian drugs and other antipsychotics. Link: ./index.php?lvl=notice_display&id=31007 [artículo] Serum antimuscarinic activity during clozapine treatment [texto impreso] / Jose de Leon, Autor ; Aruby Odom White, Autor ; Richard C. Josiassen, Autor . - 2023 . - pp. 336-341. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 336-341 Palabras clave: Clozapina, Antagonistas muscarínicos, Esquizofrenia. Resumen: This study attempts: (1) to verify that serum antimuscarinic activity is related to clozapine dose, and more importantly to clozapine plasma concentrations; (2) to explore whether norclozapine has serum antimuscarinic activity; (3) to explore whether antimuscarinic activity is related to clozapine side effects; and (4) to compare the serum antimuscarinic activities of clozapine with those of antiparkinsonian drugs and other antipsychotics. Link: ./index.php?lvl=notice_display&id=31007

Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation / Robert W. Baker en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348 Título : Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation Tipo de documento: texto impreso Autores: Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor Fecha de publicación: 2023 Artículo en la página: pp. 342-348 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008 [artículo] Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation [texto impreso] / Robert W. Baker, Autor ; Bruce J. Kinon, Autor ; Gerald Maguire, Autor . - 2023 . - pp. 342-348. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 342-348 Palabras clave: Antipsicóticos, Benzodiazepinas, Pirenzepina, Agitación psicomotora. Resumen: Patients experiencing an acute decompensation of schizophrenia or bipolar disorder often present in an agitated state. Agitation presents a barrier to therapy, interrupting the typical physician-patient alliance and creating a disruptive, even hazardous, environment. Rapid assessment and effective treatment are necessary to manage agitation and, potentially, to shorten the time to recovery. Link: ./index.php?lvl=notice_display&id=31008

Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine / Judith Hall en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 349-357 Título : Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine Tipo de documento: texto impreso Autores: Judith Hall, Autor ; Claudio A. Naranjo, Autor ; Beth A. Sproule, Autor Fecha de publicación: 2023 Artículo en la página: pp. 349-357 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alprazolam, Ansiolíticos, Antidepresivos, Interacciones medicamentosas, Fluoxetina. Resumen: The selective serotonin reuptake inhibitor antidepressant fluoxetine inhibits alprazolam metabolism in vivo by inhibition of the cytochrome P 450 3A4 enzyme. Citalopram is a selective serotonin reuptake inhibitor antidepressant that has not yet been fully evaluated with respect to its potential for cytochrome P 450 3A4-mediated drug interactions in vivo. Link: ./index.php?lvl=notice_display&id=31009 [artículo] Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine [texto impreso] / Judith Hall, Autor ; Claudio A. Naranjo, Autor ; Beth A. Sproule, Autor . - 2023 . - pp. 349-357. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 349-357 Palabras clave: Alprazolam, Ansiolíticos, Antidepresivos, Interacciones medicamentosas, Fluoxetina. Resumen: The selective serotonin reuptake inhibitor antidepressant fluoxetine inhibits alprazolam metabolism in vivo by inhibition of the cytochrome P 450 3A4 enzyme. Citalopram is a selective serotonin reuptake inhibitor antidepressant that has not yet been fully evaluated with respect to its potential for cytochrome P 450 3A4-mediated drug interactions in vivo. Link: ./index.php?lvl=notice_display&id=31009

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study / Kirsten Behnke en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 358-364 Título : Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study Tipo de documento: texto impreso Autores: Kirsten Behnke, Autor ; Jesper Søgaard, Autor ; Stephen Martin, Autor Fecha de publicación: 2023 Artículo en la página: pp. 358-364 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos Tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Sertralina, Disfunción sexual fisiológica Resumen: This multinational, randomized, double-blind study was specifically designed to prospectively compare the onset of antidepressant efficacy of mirtazapine orally disintegrating tablets and sertraline at dosages commonly used in clinical practice. A total of 345 patients with major depressive episode (DSM-IV) received mirtazapine (30–45 mg/d) or sertraline (50–150 mg/d) for 8 weeks. Link: ./index.php?lvl=notice_display&id=31010 [artículo] Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study [texto impreso] / Kirsten Behnke, Autor ; Jesper Søgaard, Autor ; Stephen Martin, Autor . - 2023 . - pp. 358-364. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 358-364 Palabras clave: Antidepresivos Tricíclicos, Trastorno depresivo, Mianserin, Mirtazapina, Sertralina, Disfunción sexual fisiológica Resumen: This multinational, randomized, double-blind study was specifically designed to prospectively compare the onset of antidepressant efficacy of mirtazapine orally disintegrating tablets and sertraline at dosages commonly used in clinical practice. A total of 345 patients with major depressive episode (DSM-IV) received mirtazapine (30–45 mg/d) or sertraline (50–150 mg/d) for 8 weeks. Link: ./index.php?lvl=notice_display&id=31010

Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine / Maurizio Fava en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369 Título : Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 365-369 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas. Resumen: The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine. Link: ./index.php?lvl=notice_display&id=31011 [artículo] Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine [texto impreso] / Maurizio Fava, Autor ; Patrick J. McGrath, Autor ; Wang Pui Sheu, Autor . - 2023 . - pp. 365-369. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 365-369 Palabras clave: Antidepresivos, Trastorno depresivo mayor, Resistencia a los medicamentos, Fluoxetina, Morfolinas. Resumen: The aim of the present study was to evaluate the efficacy and safety of an immediate switch to reboxetine, a selective noradrenaline reuptake inhibitor (selective NRI), in patients with depression unresponsive to the selective serotonin reuptake inhibitor (SSRI) fluoxetine. Link: ./index.php?lvl=notice_display&id=31011

Olanzapine versus placebo in acute mania: Treatment responses in subgroups / Ross J. Baldessarini en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 370-376 Título : Olanzapine versus placebo in acute mania: Treatment responses in subgroups Tipo de documento: texto impreso Autores: Ross J. Baldessarini, Autor ; John Hennen, Autor ; Michael Wilson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 370-376 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Modelos psicológicos, Pirenzepina. Resumen: Two double-blind, placebo-controlled trials of olanzapine in acute mania showed significant overall antimanic efficacy, based on reductions in mania ratings. Their subject-level data were pooled to increase statistical power to test for differences in treatment responses among 10 subgroup pairs of interest using generalized estimating equations methods. Link: ./index.php?lvl=notice_display&id=31012 [artículo] Olanzapine versus placebo in acute mania: Treatment responses in subgroups [texto impreso] / Ross J. Baldessarini, Autor ; John Hennen, Autor ; Michael Wilson, Autor . - 2023 . - pp. 370-376. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 370-376 Palabras clave: Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Modelos psicológicos, Pirenzepina. Resumen: Two double-blind, placebo-controlled trials of olanzapine in acute mania showed significant overall antimanic efficacy, based on reductions in mania ratings. Their subject-level data were pooled to increase statistical power to test for differences in treatment responses among 10 subgroup pairs of interest using generalized estimating equations methods. Link: ./index.php?lvl=notice_display&id=31012

Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations / Olivier Le Bon en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 377-383 Título : Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations Tipo de documento: texto impreso Autores: Olivier Le Bon, Autor ; James R. Murphy, Autor ; Luc Staner, Autor Fecha de publicación: 2023 Artículo en la página: pp. 377-383 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Antidepresivos de segunda generación, Depresores del sistema nervioso central, Etanol, Polisomnografía, Trastornos de inicio y mantenimiento del sueño, Síndrome de abstinencia de sustancias, Trazodona. Resumen: Alcohol detoxification is accompanied by sustained difficulties in sleep initiation and maintenance. These difficulties are thought to be an important cause of relapse to alcohol use. However, the treatment of sleep problems with hypnotic drug is made difficult by cross-tolerance between benzodiazepines and alcohol. Link: ./index.php?lvl=notice_display&id=31013 [artículo] Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations [texto impreso] / Olivier Le Bon, Autor ; James R. Murphy, Autor ; Luc Staner, Autor . - 2023 . - pp. 377-383. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 377-383 Palabras clave: Alcoholismo, Antidepresivos de segunda generación, Depresores del sistema nervioso central, Etanol, Polisomnografía, Trastornos de inicio y mantenimiento del sueño, Síndrome de abstinencia de sustancias, Trazodona. Resumen: Alcohol detoxification is accompanied by sustained difficulties in sleep initiation and maintenance. These difficulties are thought to be an important cause of relapse to alcohol use. However, the treatment of sleep problems with hypnotic drug is made difficult by cross-tolerance between benzodiazepines and alcohol. Link: ./index.php?lvl=notice_display&id=31013

Cocaine and amphetamine use in patients with psychiatric illness / E. Sherwood Brown en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 384-388 Título : Cocaine and amphetamine use in patients with psychiatric illness : A randomized trial of typical antipsychotic continuation or discontinuation Tipo de documento: texto impreso Autores: E. Sherwood Brown, Autor ; Vicki A. Nejtek, Autor ; Dana C. Perantie, Autor Fecha de publicación: 2023 Artículo en la página: pp. 384-388 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos relacionados con las anfetaminas, Antipsicóticos, Trastornos relacionados con la cocaína, Trastornos mentales - complicaciones Resumen: Animal studies indicate that typical antipsychotics (neuroleptics) increase cocaine and amphetamine self-administration. Patients with psychiatric illnesses have high rates of substance abuse and frequently receive chronic typical antipsychotic therapy. This open, pilot study examined the effect of typical antipsychotic discontinuation on cocaine and amphetamine use in patients with psychiatric illnesses. Link: ./index.php?lvl=notice_display&id=31014 [artículo] Cocaine and amphetamine use in patients with psychiatric illness : A randomized trial of typical antipsychotic continuation or discontinuation [texto impreso] / E. Sherwood Brown, Autor ; Vicki A. Nejtek, Autor ; Dana C. Perantie, Autor . - 2023 . - pp. 384-388. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 384-388 Palabras clave: Trastornos relacionados con las anfetaminas, Antipsicóticos, Trastornos relacionados con la cocaína, Trastornos mentales - complicaciones Resumen: Animal studies indicate that typical antipsychotics (neuroleptics) increase cocaine and amphetamine self-administration. Patients with psychiatric illnesses have high rates of substance abuse and frequently receive chronic typical antipsychotic therapy. This open, pilot study examined the effect of typical antipsychotic discontinuation on cocaine and amphetamine use in patients with psychiatric illnesses. Link: ./index.php?lvl=notice_display&id=31014

Interventions to improve antipsychotic medication adherence: review of recent literature / Christian R. Dolder en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 389-399 Título : Interventions to improve antipsychotic medication adherence: review of recent literature Tipo de documento: texto impreso Autores: Christian R. Dolder, Autor ; Jonathan P. Lacro, Autor ; Susan Leckband, Autor Fecha de publicación: 2023 Artículo en la página: pp. 389-399 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Trastornos psicóticos, Esquizofrenia. Resumen: Antipsychotic nonadherence is an important barrier to the successful treatment of schizophrenia and can lead to clinical and economic burdens. Interventions capable of significantly improving medication adherence in patients with schizophrenia would be beneficial in maximizing treatment outcomes with antipsychotics. Link: ./index.php?lvl=notice_display&id=31015 [artículo] Interventions to improve antipsychotic medication adherence: review of recent literature [texto impreso] / Christian R. Dolder, Autor ; Jonathan P. Lacro, Autor ; Susan Leckband, Autor . - 2023 . - pp. 389-399. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 4 (Agosto) . - pp. 389-399 Palabras clave: Antipsicóticos, Trastornos psicóticos, Esquizofrenia. Resumen: Antipsychotic nonadherence is an important barrier to the successful treatment of schizophrenia and can lead to clinical and economic burdens. Interventions capable of significantly improving medication adherence in patients with schizophrenia would be beneficial in maximizing treatment outcomes with antipsychotics. Link: ./index.php?lvl=notice_display&id=31015